RecruitingPhase 1ACTRN12610000983000

A pilot trial assessing the effect of fish oil on leptin and adiponectin levels in overweight/obese individuals.

A pilot trial assessing the effect of marine lipids on leptin and adiponectin levels in overweight/obese individuals.


Sponsor

Centre for Integrative Clinical and Molecular Medicine, University of Queensland

Enrollment

48 participants

Start Date

Nov 8, 2010

Study Type

Interventional

Conditions

Summary

Obesity is a global epidemic. It is associated with a high burden of chronic diseases such as type 2 diabetes mellitus (T2DM), cardiovascular disease (CVD) and some cancers. Obesity and CVD progression have been associated with altered levels of biologically active proteins secreted by adipocytes, including the hormones adiponectin and leptin. This study aims to assess the effect of a high dose marine lipid supplement [dose: 4000mg per day for 8 weeks] on plasma adiponectin and leptin levels in overweight and obese individuals.


Eligibility

Sex: Both males and femalesMin Age: 18 Yearss

Plain Language Summary

Simplified for easier understanding

This study is looking at whether taking a high-dose fish oil supplement (4,000 mg per day for 8 weeks) can change the levels of two important hormones — adiponectin and leptin — in overweight or obese adults. These hormones are linked to body fat and heart health. This is a pilot study to explore whether fish oil might help improve metabolic health in people who are overweight. You may be eligible if: - You are 18 years of age or older - Your body mass index (BMI) is 25 or greater (overweight or obese) - You are generally healthy You may NOT be eligible if: - You currently take other medications or are participating in another study - You have lost more than 10% of your body weight in the past 6 months - You smoke - You are pregnant or breastfeeding - You have an allergy to fish oil - You take anticoagulants (blood thinners) or the statin medication Pravastatin - You have a major health condition - You have a history of alcohol or drug dependency Talk to your doctor about whether this trial might be right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

Treatment with commercially available marine lipid preparation at a dose of 4 x 1000mg capsules per day (each capsule contains 300mg EPA, 200mg DHA) for a period of 8 weeks

Treatment with commercially available marine lipid preparation at a dose of 4 x 1000mg capsules per day (each capsule contains 300mg EPA, 200mg DHA) for a period of 8 weeks


Locations(1)

Australia

View Full Details on ANZCTR

For the most up-to-date information, visit the official listing.

Visit

ACTRN12610000983000


Related Trials